NCT01179815Recruiting
Swiss Diabetes Registry - SwissDiab Study
Swiss Diabetes Registry - SwissDiab Study, a Prospective Cohort Study of Patients With Diabetes in Switzerland
Source: ClinicalTrials.gov · Last updated 11 Jun 2026
Brief summary (registry, in English)
Currently, the estimated number of people with diabetes mellitus is approximately 387 million people worldwide. Due to population growth, urbanization, ageing and the rising prevalence of obesity the numbers of individuals with diabetes is increasing likewise. It has been shown that improving glycemic control is associated with a reduction in late complications of diabetes, such as cardiovascular and microvascular diseases. Therefore, treatment guidelines were established internationally by large and renowned associations and adopted by many countries. For Switzerland only sparse data exist on the actual implementation of such recommendations and on patient's well-being. The Swiss Diabetes Registry - SwissDiab Study is a prospective cohort study aiming at including and collecting data of virtually all patients regularly seen and treated at the study centers (≈ 500 patients each), irrespective of type, duration of diabetes or treatment . This allows the evaluation of diabetes treatment strategies at these centers. Furthermore, risk indicators for micro- and macrovascular complications, mortality as well as costs and quality of life will be assessed. Data will be recorded through an internet-based, electronic database specifically designed for this study. At a later perspective it is planned to extend data collection to general practitioner/family doctor networks in order to include a larger and more representative sample of patients with diabetes in Switzerland.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 10 Aug 2010
- Start date
- Jan 2010
- Primary completion date
- Jan 2099
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Diseases
- Type 1 diabetes, Type 2 diabetes
- NCT number
- NCT01179815
What you commit to
- Study type: Observational
- Planned participants: 1500
- From Jan 2010 to the primary completion date, Jan 2099
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with gestational diabetes mellitus, patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions as well as patients with significantly reduced life expectancy (\<1 year) will be excluded
Who the study is looking for
- Age \> 18 years
- Diagnosis of diabetes mellitus according to ADA criteria
- Informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern Coordinator of this site? Confirm its status | Bern | Switzerland | Recruiting |
| Service d'endocrinologie, diabétologie et métabolisme Coordinator of this site? Confirm its status | Lausanne | Switzerland | Recruiting |
| Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.Gallen Coordinator of this site? Confirm its status | Sankt Gallen | Switzerland | Recruiting |
| Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich Coordinator of this site? Confirm its status | Zurich | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.